Analysis of Arex Industries Limited (AREXMIS)
Arex Industries Limited has been showing some volatility in its stock price recently. The Relative Strength Index (RSI) values have been fluctuating around the 40-50 range, indicating a neutral to slightly bearish sentiment in the market.
The Moving Average Convergence Divergence (MACD) indicator has been negative, suggesting a bearish trend in the stock price. The MACD histogram has been consistently negative, indicating a strong bearish momentum.
The Moving Average (MA) indicator has been above the stock price, suggesting a bearish trend. The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have all been above the stock price, further confirming the bearish sentiment.
Overall, based on the RSI, MACD, and MA indicators, Arex Industries Limited seems to be in a bearish phase. Investors may want to exercise caution and closely monitor the stock for any potential trend reversals.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The stock has a market capitalization of $2.92 trillion, with 57.59% held by institutions and 5.22% held by insiders.
Valuation metrics show a PEG ratio of 26.32, forward P/E of 26.32, and trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65.
The stock price summary includes a beta of 1.264, 50-day moving average of $176.26, and 200-day moving average of $181.04. The stock's 52-week low is $164.08, high is $199.62, and the change over the past year is 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The company's dividend yield is 0.53% and the last split date was on August 31, 2020, with a 4-for-1 split. The ex-dividend date is May 10, 2024, and the dividend date is May 16, 2024.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales have been increasing over the years, from $274.52 billion in 2020 to $383.29 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown an increasing trend, from $66.29 billion in 2020 to $114.30 billion in 2023.
4. Net income has been increasing steadily, from $57.41 billion in 2020 to $96.99 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA ranging from around $81 billion to $129 billion.
7. Despite an increase in income tax expenses, the company has managed to grow its net income consistently.
8. The company has been able to control its operating expenses effectively, allowing for growth in operating income.
9. Non-operating interests have been relatively stable over the years.
10. The number of basic and diluted shares outstanding has remained stable, indicating no significant dilution of shares.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to finance its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been able to maintain a positive shareholders' equity throughout the years, indicating a healthy financial position.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities seem to be well-managed, with a focus on maintaining a healthy cash position while investing in growth and returning value to shareholders.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next fiscal year. The average estimates show an increase compared to the year-ago EPS figures, indicating growth expectations in the company's performance. It's also worth noting the varying range between low and high estimates, suggesting some uncertainty or differing opinions among analysts regarding the future earnings potential.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth over the next few years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the current price is below both the average and median predicted prices. The analysts' opinions vary, with a wide range between the low and high estimates. It is important to consider these different perspectives when making investment decisions.MACD of AREXMIS